Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
about
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functionsPAX3-FOXO1 fusion gene in rhabdomyosarcomaFusions of the SYT and SSX genes in synovial sarcoma.PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.Clinical aspects of alveolar rhabdomyosarcoma with translocation t(1;13)(p36;q14) and hypotetraploidy.Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expressionPathologic classification of rhabdomyosarcomas and correlations with molecular studies.Ewing tumor: tumor biology and clinical applications.PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcomaGene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.Neonatal alveolar rhabdomyosarcoma with skin and brain metastases.Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group.Physeal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.A rapid one-generation genetic screen in a Drosophila model to capture rhabdomyosarcoma effectors and therapeutic targetsUpdate on childhood rhabdomyosarcoma.A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.Soft tissue tumours of the retroperitoneumClinical relevance of molecular genetics to paediatric sarcomasAlveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.Diagnostic and prognostic sarcoma signatures.Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.Advances in pediatric rhabdomyosarcoma characterization and disease model development.MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma.FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma.Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.Diagnosis and classification of small round-cell tumors of childhoodPAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
P2860
Q24291233-F1BE7537-9156-4C19-A38A-037305CECEFCQ24646520-F9B34E96-754F-4203-A352-5D71594F45CDQ27824775-EC338E36-AE2B-412F-BDA8-D6901AF6070BQ33273560-FA9CBD3C-9CD1-4A1A-AC78-4451AF50D458Q33734566-9B9E2BE2-CB20-4FC0-9D43-0B870A2B2AD2Q33799662-B684DEE0-B86D-4973-BDA7-14C56CB8CD65Q33930344-17086456-03BB-44D7-B4CA-429C1C073F80Q34250993-9F93F20E-DD50-4DFD-9DAE-A453C57F083EQ34317033-01E71F56-ED8D-48A0-B554-44E70A334E9AQ34363846-3F9D42A2-D9E6-478A-B145-CFE2A29B0D37Q34405491-B6FDDD9C-CE79-4C69-AECE-90EA04510A9FQ34464264-840C921B-CE06-4343-BE2B-B1851F054D67Q34578460-883C3FC5-3A93-4F20-B1A5-EE038F7FCD21Q34929490-004FDADB-E5DC-491B-B8CF-83A2905BEB01Q35061929-3CEDECE2-B30C-40DC-9367-B9906EF6BA53Q35090205-DA455779-188D-4FCE-8143-0816FC18D2B6Q35869400-C6A314AB-C183-4658-896B-B4B05F7C0542Q36084235-7D0C30AB-8770-4DC5-A9D4-86B02FF99F06Q36142754-882F1B99-A897-4010-8A33-F8338077B379Q36643391-30FB7BAE-CAB2-4FE9-8FCB-4870E443B8B5Q36673933-3D956C36-394D-4962-A178-9B77D3C32FBAQ36674058-622C5AC8-C6F8-4FF8-B994-7092246A4EC7Q36690895-B18D2153-06EC-4246-BEAF-78ADA0D897C5Q36806186-B44BA3AD-55BE-4D70-AE15-3484510C2297Q37313616-10F802DF-A431-4D7A-8A5C-DACBE4C1C330Q37335373-9560F07A-A6BB-4216-91D2-80808F5B5374Q37466127-9718A1A6-F5CF-45D9-A730-EB567DF2D8EAQ37580831-BCC62727-7751-444A-86D2-AE0AC7B10BADQ37937737-AAA86BF1-BB9B-42A8-9243-698CB31D87E8Q38489532-EBBFB6C3-FFA9-4E0E-BA26-A19F8176B328Q38711061-13DD5F67-8951-454F-BC35-8D8DF2B81D18Q38820614-2BFD0D19-D950-4D05-8D6B-A6A17580A774Q39397196-01919D6B-6D8F-437B-946D-E7049C747EDEQ41842448-753980C5-7193-4259-9B2C-B58B2C3B28B0Q42795123-0C1228EA-B387-4BB0-AF70-45C65DCE596FQ42812291-01CAB431-B684-4CF8-9E93-0169252096A3Q52714615-52BF843A-0865-48E4-AED6-2E48C7B43824Q53331390-ECEDF9F0-164D-4621-9B2E-40A19BA1BC30
P2860
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@ast
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@en
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@nl
type
label
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@ast
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@en
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@nl
prefLabel
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@ast
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@en
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@nl
P2093
P1476
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
@en
P2093
P304
P356
10.1200/JCO.1997.15.5.1831
P407
P577
1997-05-01T00:00:00Z